UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 740

Sortiert nach

Update on Hepatitis E Virology:Implications for Clinical Practice

Journal of hepatology, 2016-07, Vol.65 (1), p.200-212

2016

Volltextzugriff (PDF)

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

Nature communications, 2022-02, Vol.13 (1), p.719-719, Article 719

2022

Volltextzugriff (PDF)

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model

The Journal of infectious diseases, 2021-09, Vol.224 (5), p.749-753

2021

Volltextzugriff (PDF)

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host

Nature communications, 2021-10, Vol.12 (1), p.6243-6243, Article 6243

2021

Volltextzugriff (PDF)

Towards antivirals against chikungunya virus

Antiviral research, 2015-09, Vol.121, p.59-68

2015

Volltextzugriff (PDF)

Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention

Reviews in medical virology, 2015-07, Vol.25 (4), p.205-223

2015

Volltextzugriff (PDF)

Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targets

Biochemical pharmacology, 2020-04, Vol.174, p.113777-113777, Article 113777

2020

Volltextzugriff (PDF)

COVID-19 and the intensive care unit: vaccines to the rescue

Intensive care medicine, 2021-07, Vol.47 (7), p.786-789

2021

Volltextzugriff (PDF)

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

Antimicrobial agents and chemotherapy, 2014-08, Vol.58 (8), p.4875-4884

2014

Volltextzugriff (PDF)

The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

PLoS neglected tropical diseases, 2016-05, Vol.10 (5), p.e0004695-e0004695

2016

Volltextzugriff (PDF)

A robust human norovirus replication model in zebrafish larvae

PLoS pathogens, 2019-09, Vol.15 (9), p.e1008009

2019

Volltextzugriff (PDF)

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

Science (American Association for the Advancement of Science), 2022-08, Vol.377 (6607), p.735-742

2022

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV‑2

Journal of medicinal chemistry, 2022-02, Vol.65 (4), p.2794-2808

2022

Volltextzugriff (PDF)

Reverse engineering synthetic antiviral amyloids

Nature communications, 2020-06, Vol.11 (1), p.2832-13, Article 2832

2020

Volltextzugriff (PDF)

The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication

Biochemical pharmacology, 2012-12, Vol.84 (11), p.1400-1408

2012

Volltextzugriff (PDF)

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19

BMC medicine, 2020-06, Vol.18 (1), p.191-9, Article 191

2020

Volltextzugriff (PDF)

CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer

Experimental cell research, 2018-11, Vol.372 (2), p.168-177

2018

Volltextzugriff (PDF)

Ribavirin Inhibits In Vitro Hepatitis E Virus Replication through Depletion of Cellular GTP Pools and Is Moderately Synergistic with Alpha Interferon

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.267-273

2014

Volltextzugriff (PDF)

Infection of zebrafish larvae with human norovirus and evaluation of the in vivo efficacy of small-molecule inhibitors

Nature protocols, 2021-04, Vol.16 (4), p.1830-1849

2021

Volltextzugriff (PDF)

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment

Nature communications, 2023-04, Vol.14 (1), p.2124-2124, Article 2124

2023

Volltextzugriff (PDF)

HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis

Biochemical pharmacology, 2018-09, Vol.155, p.305-315

2018

Volltextzugriff (PDF)

Antimicrobial, Anthelmintic, and Antiviral Activity of Plants Traditionally Used for Treating Infectious Disease in the Similipal Biosphere Reserve, Odisha, India

Frontiers in pharmacology, 2017-10, Vol.8, p.658-658

2017

Volltextzugriff (PDF)

Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral

Journal of antimicrobial chemotherapy, 2014-10, Vol.69 (10), p.2770-2784

2014

Volltextzugriff (PDF)

Advances and gaps in SARS-CoV-2 infection models

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010161

2022

Volltextzugriff (PDF)

1 – 25 von 740

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(702)
Mit Volltextzugriff
(717)

Publikationsform

Sprache

Englisch
(739)
Japanisch
(102)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(572)
Life Sciences & Biomedicine
(513)
Humans
(327)
Antiviral Agents - Pharmacology
(291)
Pharmacology & Pharmacy
(282)
Animals
(252)
Antiviral Agents
(202)
Virology
(190)
Virus Replication - Drug Effects
(173)
Biological And Medical Sciences
(172)
Medical Sciences
(154)
Pharmacology. Drug Treatments
(142)
Antiviral Agents - Chemistry
(136)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(129)
Chemistry, Medicinal
(124)
Cell Line
(98)
Microbiology
(94)
Mice
(91)
Physical Sciences
(82)
Chemistry
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Update on Hepatitis E Virology:Implications for Clinical Practice

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host

Towards antivirals against chikungunya virus

Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention

Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targets

COVID-19 and the intensive care unit: vaccines to the rescue

Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture

The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model

A robust human norovirus replication model in zebrafish larvae

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV‑2

Reverse engineering synthetic antiviral amyloids

The role of phosphatidylinositol 4-kinases and phosphatidylinositol 4-phosphate during viral replication

A prospect on the use of antiviral drugs to control local outbreaks of COVID-19

CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer

Ribavirin Inhibits In Vitro Hepatitis E Virus Replication through Depletion of Cellular GTP Pools and Is Moderately Synergistic with Alpha Interferon

Infection of zebrafish larvae with human norovirus and evaluation of the in vivo efficacy of small-molecule inhibitors

Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment

HCV-induced EGFR-ERK signaling promotes a pro-inflammatory and pro-angiogenic signature contributing to liver cancer pathogenesis

Antimicrobial, Anthelmintic, and Antiviral Activity of Plants Traditionally Used for Treating Infectious Disease in the Similipal Biosphere Reserve, Odisha, India

Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral

Advances and gaps in SARS-CoV-2 infection models

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir

Suchergebnisse filtern